Intravenous Magnesium: Prompt use for Asthma in Children Treated in the Emergency Department (IMPACT-ED), a pilot randomized trial.

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

The researchers conducted a pilot trial to test procedures and gather information to plan a large multicenter trial.

Why It Was Studied

Asthma is the most common chronic illness of childhood and a leading cause of hospitalization and health care costs for children.

Intravenous magnesium sulfate (IVMg) may help severely ill children avoid hospitalization when added to standard treatment in an emergency department (ED), but this has not been adequately evaluated in a large trial.

Who Took Part

The age groups tagged for this paper are young children, children and teenagers, both men and women.

How the Study Was Run

In design terms this was a randomized, double-blind, placebo-controlled, multicenter and pilot study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Blinding on both sides kept the participants and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.

Some participants received a placebo instead of Vitamin D, K2, Magnesium and Zinc, giving a reference point.

Running at several centres spread the Vitamin D, K2, Magnesium and Zinc study over different clinics and patient groups.

What Was Measured

Intravenous magnesium sulfate (IVMg) may help severely ill children avoid hospitalization when added to standard treatment in an emergency department (ED), but this has not been adequately evaluated in a large trial.

Topics PubMed links to this paper include Asthma, Pilot Projects, Emergency Service, Hospital, Magnesium Sulfate, Administration, Intravenous and Anti-Asthmatic Agents.

The authors tagged it with the keywords child, feasibility studies, hospitalization, hypotension, multicenter studies and randomized controlled trials.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.

Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2025 (Academic emergency medicine : official journal of the Society for Academic Emergency Medicine), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.